Cargando…
Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis
OBJECTIVE: The aim of the study is to test the hypothesis of a positive relationship between initial dose of pancreatic enzyme replacement therapy (PERT) in infants with cystic fibrosis (CF) and optimal weight gain over the first 2 years of life. METHODS: Using the CF Foundation Patient Registry, we...
Autores principales: | Schechter, Michael S., Michel, Suzanne, Liu, Shufang, Seo, B. Woun, Kapoor, Mudra, Khurmi, Rupal, Haupt, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155359/ https://www.ncbi.nlm.nih.gov/pubmed/30052568 http://dx.doi.org/10.1097/MPG.0000000000002108 |
Ejemplares similares
-
Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy
por: Trapnell, Bruce C., et al.
Publicado: (2020) -
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study in Patients With Cystic Fibrosis Receiving Enteral Feeding
por: Stevens, John, et al.
Publicado: (2018) -
Epidemiology of Pediatric Acute Pancreatitis in Taiwan: A Nationwide Population-based Study
por: Cheng, Yu-Jyun, et al.
Publicado: (2019) -
Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis
por: Freswick, Peter N., et al.
Publicado: (2022) -
Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain
por: Hameed, Shihab, et al.
Publicado: (2010)